CD8A and non-small cell lung carcinoma: We found relatively low infiltration of CD8+ T cells in tumor parenchyma of stage IA NSCLC, but several markers, including age < 50, driver mutations in RAS‐MAPK pathway, and TMB‐H, appeared to be associated with relatively higher CD8+ T cell filtration.